2m 2m 2m 2m 2m 2m 2m
Concentra Grp (CON)
NYSE
$28.68+$0.19 (+0.65%)
Price as of Jun 23, 2026 4:10 PM EDT- $3.6BMarket Cap
- 37.29%1-Year Change
- Medical Care FacilitiesIndustry
Concentra Grp (CON)
$28.68+$0.19 (+0.65%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 2.2B +13.85% | 1.9B N/A | |
Cost of Revenue | 1.6B +12.98% | 1.4B N/A | |
Gross Profit | 613.1M +16.12% | 528.0M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 75.8M +12.86% | 67.2M N/A | |
Total Operating Expenses | 1.8B +14.65% | 1.6B N/A | |
Operating Profit | 334.0M +9.59% | 304.8M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | 0 +100.00% | -44.0M N/A | |
Interest Income and Expense and Net | 0 +100.00% | -44.0M N/A | |
Total Nonoperating Income and Expense | -1.0M N/A | N/A N/A | |
Income before Taxes | 223.8M -3.27% | 231.4M N/A | |
Income Taxes | 51.0M -14.32% | 59.5M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 166.4M -0.08% | 166.5M N/A | |
Net Income from Continuing Operations Applicable to Common | 223.8M -3.27% | 231.4M N/A | |
Basic EPS and Net Income | 1.30 -10.96% | 1.46 N/A | |
Diluted EPS and Net Income | 1.30 -10.96% | 1.46 N/A | |
Basic Weighted Average Shares | 126.6M +10.97% | 114.1M N/A | |
Diluted Weighted Average Shares | 128.3M +12.48% | 114.1M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 79.9M -56.40% | 183.3M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 79.9M -56.40% | 183.3M N/A | |
Total Current Assets | 383.1M -12.38% | 437.2M N/A | |
Accumulated Depreciation | 445.5M +9.77% | 405.9M N/A | |
Property and Plant and Equipment and Net | 225.3M +13.83% | 197.9M N/A | |
Total Long-Term Assets | 20.5M +86.01% | 11.0M N/A | |
Total Assets | 2.9B +13.38% | 2.5B N/A | |
Income Taxes Payable | 48.9M +92.70% | 25.4M N/A | |
Total Short-Term Debt | 10.7M +6.39% | 10.1M N/A | |
Total Current Liabilities | 337.2M +9.79% | 307.2M N/A | |
Total Long-Term Debt | 1.6B +6.45% | 1.5B N/A | |
Total Long-Term Liabilities | 44.5M +85.11% | 24.0M N/A | |
Total Liabilities | 2.4B +9.70% | 2.2B N/A | |
Retained Earnings | 146.4M +980.56% | 13.6M N/A | |
Total Stockholders Equity | 393.3M +42.66% | 275.7M N/A | |
Total Shares Outstanding | 128.6M +0.40% | 128.1M N/A | |
Cash Flow | |||
Cash from Operating Activities | 279.4M +1.72% | 274.7M N/A | |
Capital Expenditures | 82.3M +27.99% | 64.3M N/A | |
Cash from Investing Activities | -414.9M +482.13% | -71.3M N/A | |
Dividends Paid | 32.1M +303.03% | 8.0M N/A | |
Cash from Financing Activities | 32.1M +162.30% | -51.5M N/A | |
Financials Ratio | |||
Gross Margin | 28.34% N/A | N/A N/A | |
Operating Margin | 15.44% N/A | N/A N/A | |
Return on Assets | 6.19% N/A | N/A N/A | |
Return on Equity | 49.75% N/A | N/A N/A | |
Revenue Growth | 13.85% N/A | N/A N/A | |
Current Ratio | 1.14 N/A | N/A N/A | |
Cash Ratio | 0.24 N/A | N/A N/A | |
Debt-to-Equity Ratio | 4.00 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.55 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow